Addiction Medicine Updates

Videos

UPDATES

OPIOIDS

SBIRT

TRAINING EVENTS

Latest News & Upcoming Events

Dr. Stephen Wyatt Receives Prestigious Glaser Award

Dr. Stephen Wyatt Receives Prestigious Glaser Award

RALEIGH, NC (April 2, 2019) – Stephen Wyatt, DO, medical director of Addiction Medicine at Atrium Health in Charlotte, was awarded the Frederick B. Glaser Award on March 23 at the Addiction Medicine 2019 conference held in Asheville, NC. The biennial award, given by...

10 Things to Know About Fentanyl

10 Things to Know About Fentanyl

In 2016, the powerful drug fentanyl claimed the life of music legend Prince and has, in recent years, largely contributed to the next wave of America’s opioid crisis. Here are 10 things you should know about fentanyl. 10 Things to Know About Fentanyl Learn more about...

Feb
28
Wed
AOAAM: PCSS-MAT Office-Based Treatment for Opioid Use Disorders Webinar – 2/28/2018 @ Online Live Webcast - This training is free for AOAAM members and non-members!
Feb 28 @ 5:00 pm – 9:30 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. The first half of the training is a 4.25-hour live webcast. The second half is a 3.75-hour computer-based self-study. An examination on the computer study must be successfully completed within 30 days of the live webinar as part of the process to obtain a waiver for prescribing buprenorphine. A total of 8 hours of training is federally mandated for physicians.

Click here to register

Online registration is available until: 2/28/2018

Apr
23
Mon
Making Medication-Assisted Treatment More Meaningful: Using Evidence-based Practices to Promote Recovery: Charlotte @ Charlotte AHEC, Center for Learning and Development, Building K
Apr 23 @ 8:30 am – 4:30 pm

18MH035 - Making Medication-Assisted Treatment More Meaningful: Using Evidence-based Practices to Promote Recovery

THIS EVENT IS NEAR CAPACITY

One of the challenges of Medication-assisted Treatment (MAT) is that clients and counselors often focus on the medication and lose the balance of full recovery. This workshop will focus on how to use the evidence-based practices of motivational interviewing, Interactive Journaling®, cognitive behavioral treatment and the transtheoretical model of behavior change to broaden substance use disorder treatment beyond the “bio” (as in biopsychosocial) administration of the medication. It will help providers collaborate with clients to individualize substance use treatment based on the ASAM Criteria’s multidimensional assessment and develop person-centered services that hold clients accountable and attract them to recovery.

By registering for this conference, you are granting permission for your contact information to be shared with the NC Department of Health and Human Services Division of MH/DD/SAS, which is a joint provider of this continuing education activity. 

Objectives

  • Review the biopsychosocial framework of addiction, with an emphasis on psychosocial aspects.
  • Discuss the influence of social and environmental factors on addiction and recovery.
  • Describe the biology and psychology of addiction and evidence-based supports for recovery
  • Identify the role of medication in the biopsychosocial framework of addiction.
  • Practice strategies for including evidence-based interventions and collaboration to support effective treatment and recovery

Click here to register: Light breakfast and light lunch provided

Click here for brochure

Apr
24
Tue
Making Medication-Assisted Treatment More Meaningful: Using Evidence-based Practices to Promote Recovery: Wilmington @ South East AHEC, Pelican Classroom
Apr 24 @ 8:30 am – 4:30 pm

SEAHEC logo horizontal

One of the challenges of Medication-assisted Treatment (MAT) is that clients and counselors often focus on the medication and lose the balance of full recovery. This workshop will focus on how to use the evidence-based practices of motivational interviewing, Interactive Journaling®, cognitive behavioral treatment and the transtheoretical model of behavior change to broaden substance use disorder treatment beyond the “bio” (as in biopsychosocial) administration of the medication. It will help providers collaborate with clients to individualize substance use treatment based on the ASAM Criteria’s multidimensional assessment and develop person-centered services that hold clients accountable and attract them to recovery.

By registering for this conference, you are granting permission for your contact information to be shared with the NC Department of Health and Human Services Division of MH/DD/SAS, which is a joint provider of this continuing education activity. 

Objectives

  • Review the biopsychosocial framework of addiction, with an emphasis on psychosocial aspects.
  • Discuss the influence of social and environmental factors on addiction and recovery.
  • Describe the biology and psychology of addiction and evidence-based supports for recovery
  • Identify the role of medication in the biopsychosocial framework of addiction.
  • Practice strategies for including evidence-based interventions and collaboration to support effective treatment and recovery

Click here to register: Light breakfast and light lunch provided

Click here for brochure

Jun
15
Fri
Medication Assisted Treatment: Keeping Clients Alive Long Enough to Treat Them (REDUCED FEE – ONLY $35!) @ Charlotte AHEC, Bldg K, Classroom 17 & 18
Jun 15 @ 9:00 am – 1:15 pm

Speaker: DeAn White, M.Ed, NCC, LPCS, LCAS, CCS

Medication Assisted Treatment (MAT) has long been a controversial subject. This subject is getting even more attention now that we are in the middle of a nationwide opioid crisis. This training will discuss medication assisted treatment; its pros and its cons. We will talk about the different medications and how they work. We will also talk about harm reduction, meeting clients where they are, and the medical model. We will also talk about what our fears are as counselors and medication assisted treatment.

Charlotte AHEC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5096. Programs that do not qualify for NBCC credit are clearly identified. Charlotte AHEC is solely responsible for all aspects of the program.

Objectives

  • Have an open dialogue about Medication Assisted Treatment
  • Understand how the medications work
  • Understand the pros and cons of Medication Assisted Treatment
  • Reduce the stigma around this option

Breakfast is provided for this event. Click here to be taken to registration

Sep
5
Wed
Recovery Within Reach: Building Team Expertise in Office-Based Opioid Treatment (OBOT) @ Foundation Auditorium
Sep 5 @ 8:30 am – 12:45 pm

Opioid addiction is a chronic, relapsing brain disease that affects millions of Americans and produces a tremendous burden on the healthcare system. In 2002, U.S. physicians gained the opportunity to treat opioid-addicted patients with buprenorphine in primary care settings, commonly referred to as office-based opioid treatment (OBOT). OBOT has been shown to be effective in primary care settings and impacts public health through the reduction of opioid use, opioid overdose mortality, and transmission of infectious diseases. However, it remains underutilized.

One consistently cited barrier preventing OBOT expansion is lack of adequate clinical support given the additional needs for patient monitoring. Successful medication-assisted treatment (MAT) requires a team-based approach just like treatment for other chronic diseases. In addition, treatment is more effective when providers can use a trauma-informed and gender-responsive treatment plan.

The goal of this companion program to the AAAP Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders (the “Half and Half” Course) is to increase the comfort level and expertise of the healthcare team by outlining a team approach, trauma-informed interventions, gender-responsive care, and making recommendations for the implementation of buprenorphine OBOT.

Location
Please note: This conference is being held at the NC Medical Society Foundation Auditorium on 222 N. Person Street in Raleigh, NC 27601.
 For a map to the NC Medical Society, please click here. 

If you are a prescriber in primary care, emergency medicine, pain management, psychiatric, HIV and addiction medicine, you may interested in “Physicians’ Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders, The “Half and Half” Course on the same date.

By registering for this conference, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

Objectives

  • Describe the presented framework of office-based opioid treatment (OBOT) including practice changes, medications used, psychosocial services, and integration/coordination components
  • Utilize evidence-based interventions that are trauma-informed and gender-responsive to treat persons with substance use disorders
  • Define the roles of an effective practice team, including primary care and behavioral health clinicians, working together with patients and families, and using a systematic and cost-effective approach to provide patient-centered care for opioid and other substance use disorders
  • Increase medical and behavioral health professionals’ receptivity and capability to work collaboratively as they evaluate and manage opioid and other substance use disorders using SBIRT (screening, brief intervention and referral to treatment)
  • List key components of evidence-based and effective OBOT

Click here to be taken to registration

Click here for a program brochure

Providers’ Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders, The “Half and Half” Course @ Foundation Auditorium
Sep 5 @ 9:00 pm – 10:00 pm

Description

Opioid dependence is epidemic in the United States. While progress has been made in training providers, the gap in providing effective treatment of opioid use disorders continues to widen, moving beyond heroin addicted individuals to a much larger and diverse segment of the population. This increase is predominantly due to an alarming increase in addiction to prescription opioid analgesic medications.

Buprenorphine, the most recent addition to the pharmacotherapies available to treat opioid dependence, is novel among the opioid pharmacotherapies because of its partial agonist properties. It has been placed on Schedule III and is available by prescription from a physician’s office-based practice.

Recognizing the impact of this addiction, as well as learning how to treat opioid use disorders, are important steps in combating this ever growing medical problem. To obtain the waiver to prescribe, providers are required to take specialized training. PCSS-MAT uses the Half-and-Half format (first, 4.25 hours of face-to-face training with an instructor, followed by 3.75 hours of on-your-own-training that must be completed along with a post test). This training meets the requirements for physicians; however additional training is required for advanced practice providers.

The training focuses on specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment. Once the waiver training is completed in full, participants will receive a CME certificate of attendance from AAAP.

See brochure for complete information on credits.

By registering for this conference, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

The program is recommended for prescribers in primary care, emergency medicine, pain management, psychiatric, HIV, and addiction medicine. (Not a prescriber? CLICK HERE)

Objectives

  • Define the federal Drug Abuse Treatment Act (DATA) of 2000 and the subsequent revisions that lists the criteria needed for Office-Based Opioid Treatment (OBOT)
  • List the criteria for establishing the diagnosis of opioid dependence
  • Distinguish between spontaneous withdrawal and precipitated withdrawal as well as the appropriate methods of buprenorphine induction
  • Describe and contrast the functions of full mu agonists, partial agonists, and antagonists
  • Explain the interplay between pain and addiction, and how buprenorphine can be used to help stabilize these patients
  • Describe the basic approach used in at least three different types of non-pharmacological treatment of opioid dependence
  • Describe three symptoms of opioid withdrawal or intoxication that mimic symptoms of a psychiatric disorder
  • Describe at least three factors to consider in determining if the patient is an appropriate candidate for office-based treatment with buprenorphine
  • Describe at least three areas that should be covered in the rules and expectations communicated to patients during the patient assessment process
  • List at least three situations in which patient information, with patient identity, can be shared under current laws protecting the patient’s confidentiality 42 CFR and HIPAA
  • Reduce and minimize buprenorphine misuse and diversion
  • Describe the drug interactions of buprenorphine and pediatric exposures

Click here for a brochure

Click here for registration

Apr
7
Sun
Opioid Use Disorder Course during the NC OBGYN Society Annual Meeting @ Raleigh Marriott Crabtree Valley Hotel
Apr 7 @ 7:00 am – 12:30 pm

The ASAM Treatment of Opioid Use Disorder Course covers the highest quality, evidence- based practices for treating patients
with opioid use disorder. The combined online enduring material and live activity will provide the required 8 hours needed to
obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorder. The curriculum for this course
has been specifically designed for women’s health providers.

The ASAM Treatment of Opioid Use Disorder Course is designed for:
• Physicians, nurse practitioners, physician assistants, and clinical nurse specialists who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorder.
• Clinicians and healthcare team members working with providers who prescribe buprenorphine in office-based treatment of opioid use disorder.

Learning Objectives:
• Assess patients for the full spectrum of harmful opioid use including misuse and use disorders.
• Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone.
• Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorder.
• Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.

Schedule (in conjunction with 4-hour online course):

7:55am-12:30pm Treatment of Opioid Use Disorder Course (Nathan Mullins, MD)
9:30am-10:00am Break / Networking
12:30pm Adjourn

ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.

ACCME ACCREDITATION STATEMENT: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT: The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATA 2000 training provided through the UNC Extension for Community Health Care Outcomes for Rural Primary Care Medication Assisted Treatment (UNC ECHO for MAT) is made possible by funding from the Agency for Healthcare Research and Quality (AHRQ) Grant number: 1R18HSO25065-01.

Apr
13
Sat
Waiver Training Online PCSS Office-Based Treatment for Opioid Use Disorders Webinar @ Live Webcast
Apr 13 @ 8:00 am – 12:15 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study.An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Apr
22
Mon
Waiver Training Online PCSS Office-Based Treatment for Opioid Use Disorders Webinar @ Live Webcast
Apr 22 @ 5:00 pm – 9:15 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Apr
23
Tue
Waiver Training The ASAM Treatment of Opioid Use Disorder Course @ Shark Tank Conference Room 2nd Floor, Room #2K21
Apr 23 @ 8:00 am – 12:30 pm

The ASAM Treatment of Opioid Use Disorder Course covers all evidence-based practices and medications for treating patients with opioid use disorder. Physicians will be eligible to apply for the DEA DATA 2000 waiver after completion of this course.

The ASAM Treatment of Opioid Use Disorder Course is designed for:
• Physicians, nurse practitioners, physician assistants, and healthcare team members working with patients with opioid use disorder.
• Physicians, nurse practitioners, and physician assistants who wish to
obtain a waiver to prescribe buprenorphine in office-based treatment of
opioid use disorder.

Course Format
• Blended – four hours online, four hours live
o 4 hours online: due by April 22, 2019
o 4 hours of live learning on April 23, 2019 in Morrisville, NC

Information about UNC ECHO for MAT
UNC ECHO for MAT is a research initiative to combat the opioid epidemic in NC and offers:
• One-One Mentoring
• Practice Coach Support
• DATA Waiver Training
• Case-Based Learning using the ECHO Model

DOWNLOAD EVENT FLYER

!! Anyone interested in treating opioid use disorder is welcome to join!!